Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 10 studies | 24% ± 7% | |
astrocyte | 8 studies | 30% ± 11% | |
oligodendrocyte | 8 studies | 26% ± 7% | |
microglial cell | 6 studies | 21% ± 5% | |
GABAergic neuron | 6 studies | 35% ± 19% | |
glutamatergic neuron | 5 studies | 43% ± 18% | |
epithelial cell | 5 studies | 27% ± 4% | |
fibroblast | 5 studies | 19% ± 6% | |
oligodendrocyte precursor cell | 4 studies | 27% ± 7% | |
macrophage | 4 studies | 31% ± 9% | |
adipocyte | 4 studies | 18% ± 3% | |
interneuron | 4 studies | 36% ± 20% | |
cardiac muscle cell | 3 studies | 19% ± 3% | |
ependymal cell | 3 studies | 28% ± 13% | |
endothelial cell of lymphatic vessel | 3 studies | 26% ± 6% | |
neuron | 3 studies | 28% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1241.03 | 1445 / 1445 | 100% | 16.18 | 183 / 183 |
ovary | 100% | 1471.11 | 180 / 180 | 100% | 22.01 | 430 / 430 |
brain | 100% | 1399.13 | 2640 / 2642 | 100% | 27.27 | 705 / 705 |
lung | 100% | 1186.12 | 577 / 578 | 100% | 15.74 | 1155 / 1155 |
breast | 100% | 1405.72 | 459 / 459 | 100% | 17.55 | 1116 / 1118 |
stomach | 100% | 987.14 | 359 / 359 | 100% | 12.58 | 285 / 286 |
prostate | 100% | 1028.33 | 245 / 245 | 100% | 11.11 | 500 / 502 |
uterus | 100% | 1322.73 | 170 / 170 | 100% | 14.27 | 457 / 459 |
intestine | 100% | 1143.53 | 966 / 966 | 99% | 12.07 | 524 / 527 |
thymus | 100% | 1201.85 | 653 / 653 | 99% | 14.82 | 601 / 605 |
bladder | 100% | 1281.33 | 21 / 21 | 99% | 12.85 | 500 / 504 |
kidney | 100% | 938.00 | 89 / 89 | 99% | 14.79 | 888 / 901 |
skin | 100% | 1393.55 | 1809 / 1809 | 98% | 12.40 | 464 / 472 |
pancreas | 97% | 1083.06 | 319 / 328 | 100% | 13.80 | 178 / 178 |
adrenal gland | 100% | 2001.98 | 258 / 258 | 93% | 9.66 | 213 / 230 |
liver | 100% | 788.75 | 226 / 226 | 92% | 7.44 | 374 / 406 |
adipose | 100% | 1424.02 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1623.28 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 17.30 | 29 / 29 |
spleen | 100% | 1455.14 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 12.34 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.84 | 1 / 1 |
muscle | 100% | 1421.86 | 802 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 1218.83 | 901 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 1401.16 | 835 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 8.72 | 77 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032508 | Biological process | DNA duplex unwinding |
GO_0006307 | Biological process | DNA alkylation repair |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0031594 | Cellular component | neuromuscular junction |
GO_1990391 | Cellular component | DNA repair complex |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | ASCC1 |
Protein name | Activating signal cointegrator 1 complex subunit 1 (ASC-1 complex subunit p50) (Trip4 complex subunit p50) Activating signal cointegrator 1 complex subunit 1 |
Synonyms | CGI-18 |
Description | FUNCTION: Plays a role in DNA damage repair as component of the ASCC complex . Part of the ASC-1 complex that enhances NF-kappa-B, SRF and AP1 transactivation . In cells responding to gastrin-activated paracrine signals, it is involved in the induction of SERPINB2 expression by gastrin. May also play a role in the development of neuromuscular junction. . |
Accessions | A0A5F9ZI10 E9PR40 A0A5F9ZHP1 H0YER2 ENST00000533958.1 ENST00000531048.5 Q8N9N2 ENST00000492502.2 ENST00000486689.6 ENST00000673599.1 ENST00000525286.6 A0A5K1VW55 E9PKM6 H0YE76 ENST00000526751.5 A0A5F9ZH79 ENST00000342444.8 [Q8N9N2-1] ENST00000672940.1 A0A5F9ZI37 E9PQZ6 ENST00000672121.1 ENST00000317168.11 ENST00000317126.8 [Q8N9N2-2] E9PL92 ENST00000672774.1 H0YCB3 ENST00000394915.7 [Q8N9N2-1] E9PJM2 ENST00000524829.5 E9PM82 E9PQ44 ENST00000532011.5 H0YE79 ENST00000530394.5 ENST00000461369.6 ENST00000530461.5 ENST00000671788.1 A0A5F9ZGP6 ENST00000527593.5 ENST00000672957.1 [Q8N9N2-2] |